241 related articles for article (PubMed ID: 29343613)
1. Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus.
Parajuli B; Acharya K; Bach HC; Parajuli B; Zhang S; Smith AB; Abrams CF; Chaiken I
Biochem J; 2018 Mar; 475(5):931-957. PubMed ID: 29343613
[TBL] [Abstract][Full Text] [Related]
2. Lytic Inactivation of Human Immunodeficiency Virus by Dual Engagement of gp120 and gp41 Domains in the Virus Env Protein Trimer.
Parajuli B; Acharya K; Yu R; Ngo B; Rashad AA; Abrams CF; Chaiken IM
Biochemistry; 2016 Nov; 55(44):6100-6114. PubMed ID: 27731975
[TBL] [Abstract][Full Text] [Related]
3. Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate.
Parajuli B; Acharya K; Nangarlia A; Zhang S; Parajuli B; Dick A; Ngo B; Abrams CF; Chaiken I
Biochem J; 2020 Nov; 477(21):4263-4280. PubMed ID: 33057580
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
Shahzad-ul-Hussan S; Gustchina E; Ghirlando R; Clore GM; Bewley CA
J Biol Chem; 2011 Jun; 286(23):20788-96. PubMed ID: 21471192
[TBL] [Abstract][Full Text] [Related]
5. Roles of variable linker length in dual acting virucidal entry inhibitors on HIV-1 potency via on-the-fly free energy molecular simulations.
Gossert ST; Parajuli B; Chaiken I; Abrams CF
Protein Sci; 2020 Nov; 29(11):2304-2310. PubMed ID: 32926485
[TBL] [Abstract][Full Text] [Related]
6. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I
J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202
[TBL] [Abstract][Full Text] [Related]
8. The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches.
Woodrum BW; Maxwell JD; Bolia A; Ozkan SB; Ghirlanda G
Biochem Soc Trans; 2013 Oct; 41(5):1170-6. PubMed ID: 24059504
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Env-Dependent Cell Killing by Bifunctional Small-Molecule/Peptide Conjugates.
Gaffney A; Nangarlia A; Ang CG; Gossert S; Rashad Ahmed AA; Hossain MA; Abrams CF; Smith AB; Chaiken I
ACS Chem Biol; 2021 Jan; 16(1):193-204. PubMed ID: 33410670
[TBL] [Abstract][Full Text] [Related]
10. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.
Bewley CA; Otero-Quintero S
J Am Chem Soc; 2001 May; 123(17):3892-902. PubMed ID: 11457139
[TBL] [Abstract][Full Text] [Related]
11. Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols.
Bailey LD; Kalyana Sundaram RV; Li H; Duffy C; Aneja R; Rosemary Bastian A; Holmes AP; Kamanna K; Rashad AA; Chaiken I
ACS Chem Biol; 2015 Dec; 10(12):2861-73. PubMed ID: 26458166
[TBL] [Abstract][Full Text] [Related]
12. Roles of conserved tryptophans in trimerization of HIV-1 membrane-proximal external regions: Implications for virucidal design via alchemical free-energy molecular simulations.
Gossert ST; Parajuli B; Chaiken I; Abrams CF
Proteins; 2018 Jul; 86(7):707-711. PubMed ID: 29633345
[TBL] [Abstract][Full Text] [Related]
13. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.
Fromme R; Katiliene Z; Giomarelli B; Bogani F; Mc Mahon J; Mori T; Fromme P; Ghirlanda G
Biochemistry; 2007 Aug; 46(32):9199-207. PubMed ID: 17636873
[TBL] [Abstract][Full Text] [Related]
14. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
Hong PW; Nguyen S; Young S; Su SV; Lee B
J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
[TBL] [Abstract][Full Text] [Related]
15. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
Zhang S; Holmes AP; Dick A; Rashad AA; Enríquez Rodríguez L; Canziani GA; Root MJ; Chaiken IM
Retrovirology; 2021 Oct; 18(1):31. PubMed ID: 34627310
[TBL] [Abstract][Full Text] [Related]
16. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1.
Contarino M; Bastian AR; Kalyana Sundaram RV; McFadden K; Duffy C; Gangupomu V; Baker M; Abrams C; Chaiken I
Antimicrob Agents Chemother; 2013 Oct; 57(10):4743-50. PubMed ID: 23856780
[TBL] [Abstract][Full Text] [Related]
18. Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.
Huskens D; Férir G; Vermeire K; Kehr JC; Balzarini J; Dittmann E; Schols D
J Biol Chem; 2010 Aug; 285(32):24845-54. PubMed ID: 20507987
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
Chang LC; Bewley CA
J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
[TBL] [Abstract][Full Text] [Related]
20. Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors.
Ang CG; Hossain MA; Rajpara M; Bach H; Acharya K; Dick A; Rashad AA; Kutzler M; Abrams CF; Chaiken I
Biochemistry; 2020 Feb; 59(6):818-828. PubMed ID: 31942789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
